| # | Drug | Count |
|---|---|---|
| 0 | BOSENTAN | 28 |
| 1 | SILDENAFIL CITRATE | 28 |
| 2 | SILDENAFIL | 17 |
| 3 | SILDENAFIL POWDER, | 16 |
| 4 | TREPROSTINIL | 13 |
| 5 | FUROSEMIDE | 8 |
| 6 | MACITENTAN | 8 |
| 7 | TADALAFIL | 8 |
| 8 | WARFARIN | 7 |
| 9 | AMBRISENTAN | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ILOPROST | 3 | 0.0032 |
| 1 | L-ARGININE | 1 | 0.0028 |
| 2 | BOSENTAN | 28 | 0.0006 |
| 3 | EPOPROSTENOL | 6 | 0.0005 |
| 4 | UREA | 1 | 0.0005 |
| 5 | SILDENAFIL POWDER, | 16 | 0.0004 |
| 6 | DIPYRIDAMOLE | 1 | 0.0003 |
| 7 | DOBUTAMINE | 1 | 0.0003 |
| 8 | SILDENAFIL CITRATE | 28 | 0.0002 |
| 9 | NITRIC OXIDE | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Phosphodiesterase 5 Inhibitor [EPC] | 23 |
| 1 | Prostacycline Vasodilator [EPC] | 19 |
| 2 | Endothelin Receptor Antagonist [EPC] | 14 |
| 3 | Loop Diuretic [EPC] | 11 |
| 4 | Aldosterone Antagonist [EPC] | 5 |
| 5 | Cardiac Glycoside [EPC] | 5 |
| 6 | Prostacyclin Receptor Agonist [EPC] | 4 |
| 7 | Factor Xa Inhibitor [EPC] | 3 |
| 8 | Prostacycline [EPC] | 3 |
| 9 | Benzodiazepine [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline [EPC] | 3 | 0.0032 |
| 1 | Phosphodiesterase 5 Inhibitor [EPC] | 23 | 0.0002 |
| 2 | Prostacyclin Receptor Agonist [EPC] | 4 | 0.0002 |
| 3 | Prostacycline Vasodilator [EPC] | 19 | 0.0001 |
| 4 | Endothelin Receptor Antagonist [EPC] | 14 | 0.0001 |
| 5 | Cardiac Glycoside [EPC] | 5 | 0.0001 |
| 6 | Bile Acid [EPC] | 1 | 0.0000 |
| 7 | Aldosterone Antagonist [EPC] | 5 | 0.0000 |
| 8 | Soluble Guanylate Cyclase Stimulator [EPC] | 1 | 0.0000 |
| 9 | Loop Diuretic [EPC] | 11 | 0.0000 |